HOME About News Product Development Production Contact
+86-28-83188601
LANGUAGE
news center
News
Let value be shared,record brand development
当前位置 : 新闻中心 > Focus on Latin American Market | Xieli Presents at FCE Pharma 2026
Focus on Latin American Market | Xieli Presents at FCE Pharma 2026
2026-06-15

In June 2026, the Xieli team took part in FCE Pharma 2026 in São Paulo, Brazil — one of Latin America's most prominent pharma industry events, which is marking its 30th anniversary this year. Under the theme "Gathering Those Who Drive the Pharmaceutical Industry", the show brought together pharma companies, API suppliers, equipment manufacturers and industry experts from around the world to explore key industry trends and upcoming opportunities.

aaa.jpg

During the exhibition, Xieli team connected closely with pharma companies and distributors across Brazil, Argentina, Mexico and beyond, showcasing our strengths in natural product APIs and specialty raw materials, along with our end-to-end regulatory support.

bbb.jpg

As demand for high-quality APIs continues to rise across Latin America, more and more customers are prioritizing robust quality systems, proven regulatory compliance, and reliable long-term supply. Backed by our mature quality management framework, deep global market expertise, and dedicated regulatory support team, Xieli engaged in detailed discussions with a number of partners around project development, product registration, and ongoing long-term collaboration.

From our conversations at the exhibition, we've seen that what API buyers in Brazil and across Latin America prioritize is shifting well beyond simple price competition. They now place far more importance on robust quality systems, proven regulatory compliance, and end-to-end supply chain stability above all else. Meanwhile, building out secondary supply sources has become a core strategic priority for an increasing number of pharma manufacturers. Looking ahead, suppliers with proven international registration track records, consistent reliable supply capacity, and dedicated on-call technical support will be best positioned to capture the strongest growth opportunities across the Latin American market.

ccc.jpg

Moving forward, Xieli will stay committed to our global growth strategy, continuously refining our product quality, regulatory support, and end-to-end global supply chain services as we work to become the trusted global API partner of choice for pharma companies worldwide. Through ongoing innovation, consistent reliable supply, and dedicated expert support, we will keep delivering highly competitive solutions for all our partners.

Across Latin America, we will deepen our local engagement and partnerships, stay responsive to every customer's unique needs, and keep expanding the scope of our collaborations. Together with our growing network of partners, we will advance high-quality development across the pharma sector and seize new opportunities in the global market hand in hand.

ddd.jpg

We look forward to meeting more partners at our next stop and build the future together!


2026-10-17
Concluded with Distinction in Milan • Successfully Passed E...
2026-09-22
Craftsmanship of Xieli, New‑start in the Greater Bay Area |...
2026-08-28
Ingenuity in Plant‑derived Extracts, Powering Global Expans...
2026-07-09
Good News | Sichuan Xieli Pharmaceutical Awarded EcoVadis Br...
2026-06-17
New CEP Certificate Granted – Ursodeoxycholic Acid Hits New...